Isoquinoline alkaloids have multiple biological activities, which might be associated with positive pharmacological effects as well as negative adverse reactions. As bleeding was suggested to be a side effect of the isoquinoline alkaloid berberine, we decided to ascertain if different isoquinoline alkaloids could influence hemocoagulation through the inhibition of either platelet aggregation or blood coagulation. Initially, a total of 14 compounds were screened for antiplatelet activity in whole human blood by impedance aggregometry. Eight of them demonstrated an antiplatelet effect against arachidonic acid-induced aggregation. Papaverine and bulbocapnine were the most potent compounds with biologically relevant IC50 values of 26.9 ± 12.2 μM and 30.7 ± 5.4 μM, respectively. Further testing with the same approach confirmed their antiplatelet effects by employing the most physiologically relevant inducer of platelet aggregation, collagen, and demonstrated that bulbocapnine acted at the level of thromboxane receptors. None of the alkaloids tested had an effect on blood coagulation measured by a mechanical coagulometer. In conclusion, the observed antiplatelet effects of isoquinoline alkaloids were found mostly at quite high concentrations, which means that their clinical impact is most likely low. Bulbocapnine was an exception. It proved to be a promising antiplatelet molecule, which may have biologically relevant effects.

The Department of Pharmacognosy and Pharmaceutical Botany Faculty of Pharmacy in Hradec Králové Charles University 500 05 Hradec Králové Czech Republic

The Department of Pharmacology and Toxicology Faculty of Pharmacy in Hradec Králové Charles University 500 05 Hradec Králové Czech Republic

Zobrazit více v PubMed

Iranshahy M., Quinn R.J., Iranshahi M. Biologically active isoquinoline alkaloids with drug-like properties from the genus Corydalis. RSC Adv. 2014;4:15900–15913. doi: 10.1039/C3RA47944G. DOI

Derosa G., Maffioli P. Alkaloids in the nature: Pharmacological applications in clinical practice of berberine and mate tea. Curr. Top. Med. Chem. 2014;14:200–206. doi: 10.2174/1568026613666131213155252. PubMed DOI

Singh N., Sharma B. Toxicological Effects of Berberine and Sanguinarine. Front. Mol. Biosci. 2018;5:21. doi: 10.3389/fmolb.2018.00021. PubMed DOI PMC

Ai X., Yu P., Peng L., Luo L., Liu J., Li S., Lai X., Luan F., Meng X. Berberine: A review of its pharmacokinetics properties and therapeutic potentials in diverse vascular diseases. Front. Pharmacol. 2021;12:762654. doi: 10.3389/fphar.2021.762654. PubMed DOI PMC

Paul M., Hemshekhar M., Kemparaju K., Girisha K.S. Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity. Free Radic. Biol. Med. 2019;130:196–205. doi: 10.1016/j.freeradbiomed.2018.10.453. PubMed DOI

Chia Y.C., Chang F.R., Wu C.C., Teng C.M., Chen K.S., Wu Y.C. Effect of isoquinoline alkaloids of different structural types on antiplatelet aggregation in vitro. Planta Med. 2006;72:1238–1241. doi: 10.1055/s-2006-947196. PubMed DOI

Chia Y.C., Chen K.S., Chang Y.L., Teng C.M., Wu Y.C. Antiplatelet actions of aporphinoids from Formosan plants. Bioorg. Med. Chem. Lett. 1999;9:3295–3300. doi: 10.1016/S0960-894X(99)00593-4. PubMed DOI

Chen K.S., Ko F.N., Teng C.M., Wu Y.C. Antiplatelet and vasorelaxing actions of some aporphinoids. Planta Med. 1996;62:133–136. doi: 10.1055/s-2006-957835. PubMed DOI

Huang C.G., Chu Z.L., Wei S.J., Jiang H., Jiao B.H. Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells. Thromb. Res. 2002;106:223–227. doi: 10.1016/S0049-3848(02)00133-0. PubMed DOI

Saeed S.A., Gilani A.H., Majoo R.U., Shah B.H. Anti-thrombotic and anti-inflammatory activities of protopine. Pharmacol. Res. 1997;36:1–7. doi: 10.1006/phrs.1997.0195. PubMed DOI

Chen J.J., Chang Y.L., Teng C.M., Lin W.Y., Chen Y.C., Chen I.S. A new tetrahydroprotoberberine N-oxide alkaloid and anti-platelet aggregation constituents of Corydalis tashiroi. Planta Med. 2001;67:423–427. doi: 10.1055/s-2001-15820. PubMed DOI

Holy E.W., Akhmedov A., Lüscher T.F., Tanner F.C. Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells. J. Mol. Cell. Cardiol. 2009;46:234–240. doi: 10.1016/j.yjmcc.2008.10.011. PubMed DOI

Zahari A., Cheah F.K., Mohamad J., Sulaiman S.N., Litaudon M., Leong K.H., Awang K. Antiplasmodial and antioxidant isoquinoline alkaloids from Dehaasia longipedicellata. Planta Med. 2014;80:599–603. doi: 10.1055/s-0034-1368349. PubMed DOI

Chlebek J., Doskocil I., Hulcová D., Breiterová K., Šafratová M., Havelek R., Habartová K., Hošt’álková A., Volštátová T., Cahlíková L. Cytotoxicity of naturally occurring isoquinoline alkaloids of different structural types. Nat. Prod. Commun. 2016;11:753–756. doi: 10.1177/1934578X1601100614. PubMed DOI

Chen H.Y., Ye X.L., Cui X.L., He K., Jin Y.N., Chen Z., Li X.G. Cytotoxicity and antihyperglycemic effect of minor constituents from Rhizoma Coptis in HepG2 cells. Fitoterapia. 2012;83:67–73. doi: 10.1016/j.fitote.2011.09.014. PubMed DOI

Gay L.J., Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat. Rev. Cancer. 2011;11:123–134. doi: 10.1038/nrc3004. PubMed DOI PMC

Mezouar S., Frère C., Darbousset R., Mege D., Crescence L., Dignat-George F., Panicot-Dubois L., Dubois C. Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences. Thromb. Res. 2016;139:65–76. doi: 10.1016/j.thromres.2016.01.006. PubMed DOI

Habartova K., Havelek R., Seifrtova M., Kralovec K., Cahlikova L., Chlebek J., Cermakova E., Mazankova N., Marikova J., Kunes J., et al. Scoulerine affects microtubule structure, inhibits proliferation, arrests cell cycle and thus culminates in the apoptotic death of cancer cells. Sci. Rep. 2018;8:4829. doi: 10.1038/s41598-018-22862-0. PubMed DOI PMC

Sirakanyan S.N., Hrubša M., Spinelli D., Dias P., Kartsev V., Carazo A., Hovakimyan A.A., Pourová J., Hakobyan E.K., Karlíčková J., et al. Synthesis of 3,3-dimethyl-6-oxopyrano[3,4-c]pyridines and their antiplatelet and vasodilatory activity. J. Pharm. Pharmacol. 2021;74:rgab075. doi: 10.1093/jpp/rgab075. PubMed DOI

Boswell-Smith V., Spina D., Page C.P. Phosphodiesterase inhibitors. Br. J. Pharmacol. 2006;147:S252–S257. doi: 10.1038/sj.bjp.0706495. PubMed DOI PMC

Az-Ma T., Saeki N., Yuge O. Differential action of spasmolytic vasodilators on platelet aggregation and endothelial cell-dependent anti-aggregation. Acta. Anaesthesiol. Scand. 2000;44:417–422. doi: 10.1034/j.1399-6576.2000.440410.x. PubMed DOI

Vigdahl R.L., Mongin J., Jr., Marquis N.R. Platelet aggregation. IV. Platelet phosphodiesterase and its inhibition by vaso-dilators. Biochem. Biophys. Res. Commun. 1971;42:1088–1094. doi: 10.1016/0006-291X(71)90016-7. PubMed DOI

Mladěnka P., Applová L., Patočka J., Costa V.M., Remiao F., Pourová J., Mladěnka A., Karlíčková J., Jahodář L., Vopršalová M., et al. Comprehensive review of cardiovascular toxicity of drugs and related agents. Med. Res. Rev. 2018;38:1332–1403. doi: 10.1002/med.21476. PubMed DOI PMC

Woo S.H., Sun N.J., Cassady J.M., Snapka R.M. Topoisomerase II inhibition by aporphine alkaloids. Biochem. Pharmacol. 1999;57:1141–1145. doi: 10.1016/S0006-2952(99)00018-0. PubMed DOI

D’Yakonov V.A., Dzhemileva L.U., Dzhemilev U.M. Chapter 2—Advances in the chemistry of natural and semisynthetic topoisomerase I/II inhibitors. Stud. Nat. Prod. Chem. 2017;17:21–86. doi: 10.1016/B978-0-444-63929-5.00002-4. DOI

Ortiz L.M.G., Lombardi P., Tillhon M., Scovassi A.I. Berberine, an epiphany against cancer. Molecules. 2014;19:12349–12367. doi: 10.3390/molecules190812349. PubMed DOI PMC

Fakouhi T., Darby T.D., McCutcheon R.S. Cardiovascular effects of bulbocapnine. J. Pharm. Sci. 1971;60:1045–1048. doi: 10.1002/jps.2600600709. PubMed DOI

Łabuz-Roszak B., Pierzchała K., Tyrpień K. Resistance to acetylsalicylic acid in patients with type 2 diabetes mellitus is associated with lipid disorders and history of current smoking. J. Endocrinol. Invest. 2014;37:331–338. doi: 10.1007/s40618-013-0012-2. PubMed DOI PMC

Gao M., Chen L., Yang L., Yu X., Kou J., Yu B. Berberine inhibits LPS-induced TF procoagulant activity and expression through NF-κB/p65, Akt and MAPK pathway in THP-1 cells. Pharmacol. Rep. 2014;66:480–484. doi: 10.1016/j.pharep.2013.12.004. PubMed DOI

Chlebek J., Macáková K., Cahlíkova L., Kurfürst M., Kunes J., Opletal L. Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava (Fumariaceae) Nat. Prod. Commun. 2011;6:607–610. doi: 10.1177/1934578X1100600507. PubMed DOI

Cahlíková L., Macáková K., Kunes J., Kurfürst M., Opletal L., Cvacka J., Chlebek J., Blundene G. Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Eschscholzia californica (Papaveraceae) Nat. Prod. Commun. 2010;5:1035–1038. doi: 10.1177/1934578X1000500710. PubMed DOI

Chlebek J., Novák Z., Kassemová D., Šafratová M., Kostelník J., Malý L., Ločárek M., Opletal L., Hošt’álková A., Hrabinová M., et al. Isoquinoline Alkaloids from Fumaria officinalis L. and their biological activities related to Alzheimer’s disease. Chem. Biodivers. 2016;13:91–99. doi: 10.1002/cbdv.201500033. PubMed DOI

Cahlíková L., Opletal L., Kurfürst M., Macáková K., Kulhánková A., Hostálková A. Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Chelidonium majus (Papaveraceae) Nat. Prod. Commun. 2010;5:1751–1754. doi: 10.1177/1934578X1000501110. PubMed DOI

Tóth O., Calatzis A., Penz S., Losonczy H., Siess W. Multiple electrode aggregometry: A new device to measure platelet aggregation in whole blood. Thromb. Haemost. 2006;96:781–788. doi: 10.1160/TH06-05-0242. PubMed DOI

Cayman Chemical Company COX Inhibitor Screening Assay Kit. 2019a. [(accessed on 1 March 2019)]. Available online: https://www.caymanchem.com/app/template/Product.vm/catalog/560131.

Cayman Chemical Company Thromboxane B2 EIA Kit. 2019b. [(accessed on 1 March 2019)]. Available online: https://www.caymanchem.com/product/501020.

Karlíčková J., Říha M., Filipský T., Macáková K., Hrdina R., Mladěnka P. Antiplatelet effects of flavonoids mediated by inhibition of arachidonic acid based pathway. Planta Med. 2016;82:76–83. doi: 10.1055/s-0035-1557902. PubMed DOI